Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 27241-184

11 FDA label images from Ajanta Pharma Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 27241-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (Lamotrigine 100mg)

100mg (Lamotrigine 100mg)
Lamotrigine Orally Disintegrating Tablets 100 mg label from Ajanta Pharma USA Inc., containing 30 tablets. The label includes child-resistant packaging warnings, storage instructions, and pharmacist dispensing cautions. The product is marketed by Ajanta Pharma USA Inc., Bridgewater, NJ, and made in India.*
FDA Label Image

200mg (Lamotrigine 200mg)

200mg (Lamotrigine 200mg)
Label for Lamotrigine Orally Disintegrating Tablets 200 mg, an oral prescription tablet. The package contains 30 tablets. The label includes the NDC number 27241-186-30 and states the product is marketed by Ajanta Pharma USA Inc. It emphasizes child-resistant packaging and storage instructions at controlled room temperature.*
FDA Label Image

25mg (Lamotrigine 25mg)

25mg (Lamotrigine 25mg)
Label for Lamotrigine Orally Disintegrating Tablets 25 mg, containing 30 tablets. The label indicates the product is child-resistant and advises storage between 20°C to 25°C, with permitted excursions. The medication is marketed by Ajanta Pharma USA Inc. The label also includes dispensing cautions, NDC 27241-183-30, and features a barcode.*
FDA Label Image

50mg (Lamotrigine 50mg)

50mg (Lamotrigine 50mg)
Lamotrigine Orally Disintegrating Tablets 50 mg carton label showing 30 tablets. Label includes dosage strength, NDC 27241-184-30, and states the product is child-resistant with storage instructions. Marketed by Ajanta Pharma USA Inc., Bridgewater, NJ. Barcode visible on the right side.*
FDA Label Image

100mg (Lamotrigine 100mg)

100mg (Lamotrigine 100mg)
Lamotrigine 100 mg orally disintegrating tablet. The image shows a round, white tablet with the imprint 'LTG' on one side and a smooth, unmarked reverse side. The tablet is intended for oral administration and is labeled under Ajanta Pharma USA Inc.*
FDA Label Image

200mg (Lamotrigine 200mg)

200mg (Lamotrigine 200mg)
Lamotrigine 25 mg orally disintegrating tablets. The image shows two white, round tablets, one with the imprint "LTS" and the other plain. These are single-dose units without visible packaging details. Labeler is Ajanta Pharma USA Inc.*
FDA Label Image

25mg (Lamotrigine 25mg)

25mg (Lamotrigine 25mg)
Lamotrigine 50 mg orally disintegrating tablet. The image shows a white, round tablet with a score line on one side and the imprint 'L1' on the other. This tablet form is designed for oral administration and is manufactured by Ajanta Pharma USA Inc.*
FDA Label Image

50mg (Lamotrigine 50mg)

50mg (Lamotrigine 50mg)
Lamotrigine 25 mg orally disintegrating round white tablet. One side is scored with the imprint LTS and the other side is plain. Manufactured by Ajanta Pharma USA Inc.*
FDA Label Image

Structure (Lamotrigine Structure)

Structure (Lamotrigine Structure)
Chemical structure of lamotrigine, an anticonvulsant medication. The diagram shows the molecular components including chlorine atoms, amino groups, and a triazine ring system characteristic of lamotrigine.*
FDA Label Image

Figure1 (Lamotriginefigure1)

Figure1 (Lamotriginefigure1)
A Kaplan-Meier failure probability plot comparing Lamotrigine and placebo over approximately 100 weeks. The graph shows failure probability percentage on the vertical axis and weeks on the horizontal axis, with distinct lines for Lamotrigine and placebo groups, along with censored data points indicated.*
FDA Label Image

Figure2 (Lamotriginefigure2)

Figure2 (Lamotriginefigure2)
A Kaplan-Meier failure probability curve showing failure probability percentage over weeks for Lamotrigine and Placebo groups. The graph includes censored data points marked as '+'. The Placebo group shows a higher failure probability over time compared to the Lamotrigine group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.